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ABSTRACT
Gene trapping is used to introduce insertional muta-
tions into genes of mouse embryonic stem cells
(ESCs). It is performed with gene trap vectors that
simultaneously mutate and report the expression of
the endogenous gene at the site of insertion and
provide a DNA tag for rapid identification of the dis-
rupted gene. Gene traps have been employed world-
wide to assemble libraries of mouse ESC lines
harboring mutations in single genes, which can be
used to make mutant mice. However, most of the
employed gene trap vectors require gene expres-
sion for reporting a gene trap event and therefore
genes that are poorly expressed may be under-
represented in the existing libraries. To address
this problem, we have developed a novel class of
gene trap vectors that can induce gene expres-
sion at insertion sites, thereby bypassing the pro-
blem of intrinsic poor expression. We show here
that the insertion of the osteopontin enhancer into
several conventional gene trap vectors significantly
increases the gene trapping efficiency in high-
throughput screens and facilitates the recovery of
poorly expressed genes.
INTRODUCTION
Gene trapping is a high-throughput approach that is used
to introduce insertional mutations across the mouse
genome. It is performed with gene trap vectors that simul-
taneously mutate and report the expression of the endo-
genous gene at the site of insertion and provide a DNA tag
for the rapid identiﬁcation of the disrupted gene. The
generation of mutant mice from a comprehensive collec-
tion of mouse embryonic stem cell (ESC) lines harboring
gene trap insertions in single genes can be applied to
large-scale functional analysis of the  25000 mammalian
genes. As gene trap vectors insert randomly throughout
the genome, a signiﬁcant number of ESC mutations can
be generated within a limited number of experiments (1).
The most widely used gene traps consist of a promoter-
less reporter and/or selectable marker gene ﬂanked by
an upstream splice acceptor (SA) site and a downstream
polyadenylation sequence [poly(A)]. When inserted into
an intron of an expressed gene, the gene traps are tran-
scribed from an endogenous promoter, yielding fusion
transcripts in which the upstream exons are spliced to
the reporter/selectable marker gene. Since transcription
is terminated prematurely at the inserted polyadenyla-
tion site, the processed fusion transcript encodes a trun-
cated and nonfunctional version of the cellular protein
plus the reporter/selectable marker, or—if the insertion
is upstream of initiating methionines—just encodes the
reporter selectable/marker. Gene traps have been used
by both academic and commercial organizations to
create libraries of mouse ES cell lines harboring muta-
tions in single genes, which can be used to make mutant
mice (2–4). Collectively, it has been estimated that the
existing gene trap resources cover about 65% of all pro-
tein coding genes in the mouse genome (5). Since most of
these resources employed gene trap vectors whose activa-
tion is dependent on gene expression, it is likely that
the genes not yet covered by the resources are either not
expressed or are expressed too weakly to trigger a produc-
tive gene trap event.
To address this problem, vectors have been developed
for trapping genes independently of their expression. These
vectors contain a reporter/selectable marker gene ﬂanked
by an upstream constitutive promoter and a downstream
splice donor site. After inserting into an intron of any
gene, the selectable marker is expressed from the exog-
enous promoter and spliced to the downstream exons
of the trapped gene. By acquiring the endogenous
poly(A) site, the resulting fusion transcript is stabilized
and exported to the cytosol for further processing.
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However, due to a nonsense-mediated decay mecha-
nism, fusion transcripts initiated upstream of the last
exon junctions are degraded, imposing a strong bias
toward insertions into the most 30-introns, which are
usually not highly mutagenic. This problem has been suc-
cessfully addressed by inserting an internal ribosomal
entry site downstream of the selectable marker gene,
thereby eﬀectively shifting the insertions toward the
50-end of genes (8). A drawback of this shift, however, is
that the inevitably larger fusion transcripts expressed from
the exogenous promoter often include the entire coding
sequence of the disrupted gene. Thus, unless this exogen-
ous promoter is postinsertionally removed, many of the
mutations induced by the ‘improved’ poly(A) traps will be
neutralized by the expression of endogenous proteins that
maintain residual function. Moreover, as has been
recently reported, poly(A) traps preferentially integrate
into expressed genes albeit to a lesser extent than the con-
ventional gene trap vectors (9). This prompted us to test
whether increasing gene expression would make more
genes accessible to trapping. We show here that the inser-
tion of the osteopontin enhancer into several conditional
gene trap vectors signiﬁcantly increases the gene trapping
eﬃciency in high-throughput screens and facilitates the
recovery of poorly expressed genes.
METHODS
Plasmids
pFlipRosabgeo was assembled in pBabeSrf, a modiﬁed
pBabepuro retroviral vector lacking the promoter and
enhancer elements from the 30LTR as previously described
(10). For eFlipRosabgeo, six Oct4 responsive elements
from the osteopontin gene consisting of the annealed oli-
gonucleotides 50-GAT CCT GCA CTG ACC TTT CAG
CTT TGT ATA ATG TAA GTT AAA ATC ACA TTT
GAA ATG CAA ATG GAA AAG CA-30 and 50-GAT
CTG CTT TTC CAT TTG CAT TTC AAA TGT GAT
TTT AAC TTA CAT TAT ACA AAG CTG AAA GGT
CAG TGC AG-30 (11), were ﬁrst assembled head to tail in
the intermediate pEGFP–N1 (Clontech, Heidelberg;
Genebank #U55762) using the BamHI/BglII sites in the
polylinker. Subsequently the enhancer array was removed
from pEGFP-N1 as a BamHI/BglII fragment and
cloned into a BglII site located between the 50 heterotypic
frt/F3 sites of pFlipRosabgeo. pFlipRosabgeo
  and
eFlipRosabgeo
  were generated by PCR ampliﬁcation
of neo
  from pD383 (12) and subsequent cloning of
the ampliﬁed fragment into pFlipRosabgeo and
eFlipRosabgeo via a SphI restriction sites.
The pCAGGS-FLPe expression plasmid was a gift from
A. Francis Stewart (13). The pCAGGS-Cre expression
plasmid was derived from pCAGGS-FLPe by replacing
the FLPe cDNA with the Cre cDNA of pSG5Cre (14).
ES-cell cultures,infections and electroporations
The [C57BL/6J 129S6/SvEvTac] F1 ES cell lines were
grown on irradiated or mitomycin C-treated MEF feeder
layers in the presence of 1000U/ml of leukemia inhib-
itory factor (LIF) (Esgro
R, Chemicon Intl., Hofheim,
Germany), as previously described (4).
The E14Tg2a.4 [129P2] ES cell lines were grown
without feeders on gelatinized dishes in the presence of
1500U/ml of LIF.
Gene trap retrovirus was produced in Phoenix-Eco
helper cells using the transient transfection strategy
described previously (15). ESCs were infected with the
virus containing supernatants at an M.O.I. <0.5 as pre-
viously described (4). Gene trap expressing ES-cell lines
were selected in 130mg/ml G418 (Invitrogen), manually
picked, expanded and stored frozen in liquid nitrogen.
Electroporations were carried out at 240V in 0.4-mm
cuvettes using 1 10
7 ESCs, 10mg of plasmid DNA and
a 500-mF capacitator (BioRad, Hercules, USA) as pre-
viously described (16). After incubating for 2 days in
medium supplemented with 0.6mg/ml puromycin (Sigma-
Aldrich, Mu ¨ nchen, Germany), the cells were trypsinized
and seeded at low density (1000 cells/dish) onto 60-mm
Petri dishes. Emerging clones were manually picked after
9 days and expanded.
Nucleic acids andprotein analyses
PCRs were performed according to standard protocols
using 300–500ng of genomic DNA or 1mg of reverse-
transcribed total RNA in a total volume of 50ml. The
primer sequences used are available upon request. For
high-throughput splinkerette PCR, genomic DNA isola-
tion, restriction digests, ligation reactions and product
puriﬁcation were performed semiautomatically in 96-
and 384-well microtiter plates using the MWG-Biotech
RoboAmp4200 and the Beckman Coulter Biomek 2000
Robot machines as previously described (17). The
primer sequences used are available upon request.
High-throughput, semiautomated 50-RACE and
sequencing were performed as previously described (4).
Real-time RT–PCR analysis of gene expression in ESCs
was performed using SYBR green chemistry (ABgene,
Epsom, UK) and an iCycler (Biorad) machine. cDNA
was synthesized from total RNA using random priming
and Superscript II (Invitrogen) reverse transcriptase.
Gene-speciﬁc primers (20–22 mer) were designed to
anneal to the exon upstream of the insertion site and to
bgeo to amplify fusion transcript fragments between 100
and 250nt (i.e. P046C04: 50-CTT TCC CGG CTG CAA
GAT G-30; P047C11: 50-CTT TCT ACC CGC GGT CTC
C-30; P048G9: 50-CCT CCG TCA GCG ACC CAT G-30;
B32: 50-CAA GGC GAT TAA GTT GGG TAA CG-30).
Gene-speciﬁc primers for the ampliﬁcation of transcripts
expressed by genes adjacent to insertion site were designed
to anneal to two consecutive exons and are available on
request. PCR reactions were run as triplicates on 96-well
plates, with each reaction containing cDNA derived
from 7.5 to 15ng of total RNA, 5pmol of each primer,
and 1  ABsolute SYBR ﬂuorescein mix (ABGene) in a
25-ml volume and normalized to simultaneously carried
out PCRs for RNApolII (mmRPII s: 50-ATG AGC
TGG AAC GGG AAT TTG A-30; mmRPII as: 50-ACC
ACT TTG ATG GGA TGC AGG T-30). The temperature
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15s, 608C for 30s and 728C for 30s.
Western blots were performed as previously described
(18), using anti-mouse Oct4 (Abcam, Cambridge, UK)
and tubulin (Dianova, Hamburg, Germany) primary
antibodies.
Chromatin immunoprecipitation (ChiP)
Immunoprecipitation of chromatin was performed as
described by Riecke and Bielinsky (19). Brieﬂy, ESCs
were treated with 1% formaldehyde at room temperature
for 15min. The reaction was saturated by adding glycine
to a ﬁnal concentration of 125mM. Cells were lysed and
soniﬁed. One milligram of whole-cell extract was subjected
to immunoprecipitation using 3mg of anti-Oct4 antibody
(Abcam) or 3-mg anti-V5 antibody (Invitrogen) as a spe-
ciﬁcity control. Crosslinks were reversed and immunopre-
cipitated chromatin was puriﬁed using a GeneElute PCR
kit (Sigma). The puriﬁed DNA was subjected to PCR using
endogeous osteopontin and gene trap speciﬁc primers
(osteopontin=P27 5-AAGATATCTTTGTTTCTTTCA
GC-30x P34: 50-TATTTGTGTGCCTTTTCTACCTC-30,
gene trap=P29: 50-ATCGATTCAAGCCACTATGC-
30x B032: 50- CAAGGCGATTAAGTTGGGTAACG- 30.
PCR products were resolved on 1% agarose gels and visua-
lized by ethidium bromide staining.
Gene trapsequence tag processing and annotation
Genomic sequence tags were processed as previously
described (17). Similarity searches were performed in the
ENSEMBL (v49.37) and NCBI mouse genome reference
(build 37) databases using the BLASTN algorithm and
an e-value <1e
 6. Based on the genome coordinates
obtained, tags were annotated to ENSEMBL protein
coding and EST genes. Insertions into genomic regions
without any annotation were considered intergenic.
Insertions were considered ‘antisense’ when sequence
tags mapped the noncoding (antisense) strand of anno-
tated protein-coding or EST genes. Gene expression
values for trapped ENSEMBL genes were derived from
GEO series accession GSE8128 (9) (http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE8128).
For mapping antisense insertions to regions of naturally
occurring antisense transcripts, we used the annotations
assembled in the Natural Antisense Transcripts Database
(NATsDB) (http://natsdb.cbi.pku.edu.cn/) (20).
RESULTS
Conceptof enhanced gene trapping
The concept of enhanced gene trapping is based on the
prediction that a transcriptional enhancer placed into an
intron of a gene by means of a gene trap vector would
activate the gene trap by inducing gene expression at the
insertion site (Figure 1A). To test this, we inserted six
copies of a modiﬁed enhancer derived from the ﬁrst
intron of the osteopontin gene into the previously reported
conditional gene trap vector—FlipRosabgeo—(10)
(Figure 1B). Such an array of osteopontin enhancer
elements (OPEs) has been shown to activate gene expres-
sion by up to 70-fold when introduced into undiﬀeren-
tiated ESCs along with a luciferase reporter (11). Since
OPE activity is dependent on Oct4 transcription factor
binding (11), most if not all of the OPE eﬀects should
be restricted to pluripotent ESCs in which Oct4 is diﬀer-
entially expressed.
The OPE induces geneexpression atinsertions sites
To investigate whether the OPE induces the expression of
trapped genes, we took advantage of the conditional fea-
tures of the eFlipRosabgeo vector (Figure 1B) whose
SAbgeopA cassette can undergo directional inversions in
the presence of FLPe and/or Cre site-speciﬁc recombi-
nases. As has been previously reported, consecutive expo-
sure of FlipRosabgeo gene trap insertions to FLPe and
Cre recombinases inverts the SAbgeopA cassette from
coding to noncoding strands and back (10). Since the
OPE is excised from eFlipRosabgeo during the FLPe
inversion, a subsequent re-inversion induced by Cre pro-
vides an enhancerless variant of the original gene trap
allele (Figure 2A, Supplementary Figure 1). Assuming
that the OPE induces gene expression, we expected the
enhancerless allele to express less bgeo. To test this, we
cotransfected three eFlipRosabgeo lines derived from a
gene trap screen (see below) with FLPe and Cre expres-
sion plasmids and isolated re-inverted subclones with
enhancerless alleles (Figure 2A). Quantiﬁcation of bgeo
transcripts by qRT-PCR consistently revealed a decreased
bgeo expression from the enhancerless alleles (Figure 2B).
To ensure that this eﬀect was caused by the loss of the
Figure 1. Graphic illustration of enhanced gene trapping. (A) Mecha-
nism of enhanced gene trap activation. Insertion of the osteopontin
enhancer (OPE) into an intron of a gene via a gene trap vector acti-
vates the endogenous promoter by binding the transcription factor
Oct4. The induced promoter sets oﬀ the expression of the gene trap
cassette, resulting in a productive gene trap event. (B) Enhanced con-
ditional gene trap vector –‘eFlipRosabgeo’. E, exon; OPE, osteopontin
enhancer elements; SA, splice acceptor; pA, polyadenylation sequence;
LTR, long terminal repeat; frt/F3, heterotypic FLPe recombinase target
sequences; loxP/lox5171, heterotypic Cre recombinase target sequences;
bgeo, b-galactosidase/neomycinposphotransferase fusion gene.
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estimated the levels of Oct4 in the trapped ESC lines
before and after recombination. Figure 2B shows that
Oct4 levels were stable, strongly suggesting that the loss
of the enhancer is directly responsible for the reduced bgeo
transcribed from the recombined gene trap alleles.
To conﬁrm these ﬁndings on a larger scale, we anal-
yzed a set of 645 eFlipRosabgeo and 983 FlipRosabgeo
gene trap clones for which the genomic splinkerette
adaptor (SPLK) PCR was used along with 50-RACE
for gene identiﬁcation. Unlike SPLK tags obtained
directly from the genomic integration sites, RACE tags
are derived from fusion transcripts and, therefore, their
retrieval is entirely dependent on gene expression (17).
Consequently, the RACE success rate should improve
by elevating gene expression. Indeed, eFlipRosabgeo
increased the RACE success rate by 15%, clearly reﬂecting
the OPE’s positive eﬀect on gene expression (Figure 3).
Moreover, 95% of the RACE products revealed correct
splicing between upstream exons and the gene trap
cassette, indicating that the OPE does not interfere with
conventional gene trap reporting.
The OPE binds Oct4atgene trapinsertion sites
Totest whethertheOct4transcription factoractually binds
to the ectopic OPEs, we subjected the eFlipRosabgeo
trapped cell line P048G09 and its enhancer deleted
Figure 2. Induction of gene expression by the osteopontin enhancer (OPE). (A) Top: Schematic representation of the trapped allele before
(with enhancer) and after (without enhancer) FLPe- and Cre-mediated recombination. Positions of primers used for the allele speciﬁc PCRs are
indicated by arrows. Bottom: Allele speciﬁc PCR products resolved on 1% agarose gel stained with ethidium bromide. (B) Top: Quantitative
RT-PCR analysis of fusion transcripts using gene- and bgeo-speciﬁc primers. Results represent the mean relative expression levels SD from
three separate experiments. Bottom: Oct4 expression in the trapped and recombined ESC lines. Total protein lysates from ESC lines were subjected
to SDS–PAGE and analyzed by western blotting using anti-mouse Oct4 and tubulin antibodies. Note that Oct4 expression does not signiﬁcantly
change in the recombined subclones, indicating that the cells are still undiﬀerentiated.
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body. As expected, the antibody precipitated OPE contain-
ing fragments from the endogenous osteopontin gene
(Figure 4). However, the antibody also precipitated OPE
containing fragments from the P048G09- but not
P048G09-G1 gene trap insertion site, indicating that Oct4
physically associates with the gene trap’s OPE (Figure 4).
eFlipRosabgeo ishighly mutagenic and doesnot affect
gene expression in thevicinity of insertion sites
As expected from the reported preference of retroviral
integrations near the 50-end of genes, and from the obser-
vations made in previous trapping screens, the majority
of both FlipRosabgeo and eFlipRosabgeo insertions
occurred into the ﬁrst or second intron of a gene, suggest-
ing that the OPE does not aﬀect the usually highly muta-
genic 50-end insertion bias intrinsic to retroviruses
(Supplementary Figure 2).
To directly test the quality of the eFlipRosabgeo-
induced mutations, we selected three ESC lines with inser-
tions in X-chromosomal genes (Supplementary Table 1).
As the parental ESC line is male derived, these cell lines
provided a haploid background for the mutational analy-
sis. As expected, all genes were expressed in ESCs and
trapped cell lines expressed a fusion transcript as a result
of splicing the upstream exons to the gene trap cassette
(Figure 5A). Quantitative RT-PCR analysis revealed that
in each of these cell lines the endogenous transcripts were
reduced below 1.2% of wild-type levels, which is equiva-
lent to a null mutation (Figure 5B).
To investigate whether the OPE would aﬀect
genes upstream or downstream of the insertion sites,
we quantiﬁed the transcriptional activity for several of
these genes in the presence or absence of the OPE
Figure 3. 50-RACE eﬃciency in trapped ESC lines. The fraction
of trapped ESC cell lines for which both SPLK-tag and a RACE tag
were obtained is shown for 645 eFlipRosabgeo and 983 FlipRosabgeo
insertions.
Figure 4. Oct4 binding by the OPE in trapped ESCs. Chromatin immu-
noprecipitation was performed as described in the Methods section
using anti-Oct4 and anti-V5 antibodies. PCRs of the precipitated and
puriﬁed DNAs were performed with osteopontin gene- and gene-trap-
speciﬁc primers. P048G09, parental clone with enhancer; P048G09 G1,
recombined subclone without enhancer; MW, molecular weight stan-
dard (1kb plus ladder, Invitrogen).
Figure 5. Transcriptional analysis of X-linked mutations in
eFlipRosabgeo trapped ESC lines (also see Supplementary Table 1).
(A) Top: RT-PCR products obtained from fusion transcripts expressed
in the trapped ESC lines resolved on a 1% agarose gel stained with
ethidium bromide. Ampliﬁcation reactions were performed using
trapped gene- and bgeo- speciﬁc primers. The double bands in lane 1
correspond to alternative N-terminal splice variants of the ATRX gene.
Bottom: RT-PCR products obtained from wild-type transcripts
expressed in trapped and parental E14-ESCs resolved on a 1% agarose
gel stained with ethidium bromide. Gene-speciﬁc primers were chosen
in exons ﬂanking the intron containing the insertion. Note the com-
plete absence of detectable wild-type transcripts in the trapped ESC
clones. (B) Quantitative RT-PCR of the wild-type transcripts
shown in A. Results are derived from triplicate reactions and were
normalized to corresponding gene expression levels in E14 parental
cells (=100%).
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eFlipRosabgeo trapped cell lines, the genes adjacent to
the insertion sites were expressed at signiﬁcantly higher
levels than in wild-type cells or in postrecombination
subclones with enhancerless alleles, we concluded that
the OPE eﬀect is largely limited to the trapped genes.
This inability of the OPE to activate more distant genes
makes enhanced alleles passaged to the mouse germline
unlikely to induce phenotypes unrelated to the gene trap.
The OPE increases trappingrate inhigh-throughput screens
We have recently shown that the high-throughput imple-
mentation of the SPLK approach for trapped gene identi-
ﬁcation in combination with a more potent bgeo fusion
gene (i.e. bgeo
 ) signiﬁcantly improves the overall recov-
ery of gene trap events (17). To test whether the OPE-
induced increase in gene expression also improves gene
trapping, we compared the rate at which unique genes
were trapped by the enhanced (eFlipRosabgeo or
eFlipRosabgeo
 ) versus the nonenhanced (FlipRosabgeo
and FlipRosabgeo
 ) parental vectors, using a data set of
genomic sequence tags recovered from 1200 trapped
ESC lines per vector. Figure 6A shows that the OPE
improved the trapping eﬃciencies of both FlipRosabgeo
and FlipRosabgeo
 , conﬁrming that an increase in gene
expression makes more genes accessible to trapping. Not
unexpectedly, the highest trapping rate was observed with
eFlipRosabgeo
 , suggesting that the OPE- and bgeo
 
eﬀects on trapping are additive (Figure 6A).
To investigate whether the increased unique gene trap-
ping rates induced by the enhancer included protein-
coding genes that are poorly represented in the gene trap
libraries, we determined the eﬃciency with which each
vector trapped genes that have either never been trapped
or have been trapped only once before. As shown in
Figure 6B, 90 of the 350 unique ENSEMBL genes trapped
by eFlipRosabgeo
  (26%) belonged to this category.
When compared with FlipRosabgeo, eFlipRosabgeo
 
trapped three times more genes with poor database repre-
sentation, suggesting that the OPE renders a signiﬁcant
fraction of previously untrappable genes accessible to
trapping (Figure 6B).
Enhanced vectors also inserted more frequently into
intergenic regions and into the noncoding (antisense)
strands of annotated genes (Figure 6C). Analysis of the
nine intergenic insertions recovered from the 551
eFlipRosabgeo trapped ESC lines for which both SPLK
and RACE tags were available (Figure 3) showed that in
six of them the RACE tags matched genomic sequence
between 0.7 and 33.6kb upstream of the SPLK tags
(Supplementary Figure 3), suggesting that the tags are
from novel, nonannotated genes. The other three RACE
tags corresponded to novel 30-exons of annotated
genes (Supplementary Figure 3). Thus, by inserting with
higher frequency into intergenic regions (Figure 6C),
eFlipRosabgeo appears far better suited for novel gene
identiﬁcation and genome annotation than the conven-
tional gene trap vectors.
While the gene trap-activation mechanism from
antisense insertions remains to be established by
future experiments, the fact that 15% of the antisense
eFlipRosabgeo
  insertions mapped to naturally occurring
antisense transcripts (20), suggests that a signiﬁcant frac-
tion the enhanced gene traps disrupt noncoding genes.
eFlipRosabgeo traps poorlyexpressed genes
To directly test whether the OPE enables the trapping
of genes that are expressed too weakly for detection with
Figure 6. Gene trapping eﬃciencies with enhanced vectors. (A) Overall
trapping eﬃciency. The number of novel genes trapped was plotted
against the number of accumulating gene trap sequence tags
(GTSTs). (B) Trapping rate of hard to trap genes (httgs). ‘Hard-to-
trap genes’ are deﬁned as genes that have no entry or only one entry
in the IGTC, Omnibank I or Omnibank II gene trap libraries. The
number of hard-to-trap ENSEMBL genes trapped was plotted against
the cummulative number of unique genes trapped. Note that only
ENSEMBL protein-coding genes were considered for this analysis.
(C) Trapping rate of antisense transcripts and intergenic regions.
Results are based on SPLK tags obtained from a minimum of 1500
ECS lines trapped with each vector.
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expression values to the genes trapped with each vector
using a recently published Aﬀymetrix Chip Array data set
providing quantitative information on the expression
levels of 7435 ENSEMBL genes in undiﬀerentiated E14
ESCs (9). Figure 7 shows that the gene expression level of
the genes trapped by the two enhanced vectors—whether
evaluated as the mean, median, 90th, 75th, 25th or 10th
percentile—was signiﬁcantly lower than the expression
level of genes trapped with the corresponding non-
enhanced vectors (see also Supplementary Table 2).
Moreover, the minimum gene expression level required
to enable trapping by one of the enhanced vectors
was only half the level of that required for trapping by
the corresponding non-enhanced vector (Table 1,
Supplementary Table 2).
DISCUSSION
In the present study we have developed and validated a
novel class of conditional gene trap vectors that activate
gene expression at their insertion sites. Activation is
achieved by Oct4 transcription factor binding to ectopic
OPEs inserted into the target genes via gene trap vectors.
By activating gene expression, these vectors make more
genes accessible to trapping including genes that are
poorly represented in the gene trap libraries. Since the
increase in trappability also included antisense transcripts
and intergenic regions, enhanced gene trapping will
improve genome annotation and also aid the functional
analysis of the over 40000 antisense transcripts that are
thought to be expressed in mouse genome (21).
The enhanced vectors are highly mutagenic, report bona
ﬁde gene trap events and have no eﬀect on genes neighbor-
ing the insertion sites. Thus, enhanced alleles may be used
directly for generating knockout mice as they are unlikely
to complicate interpretation of the resulting phenotypes.
Recently published quantitative gene expression data in
E14 ESCs (22), makes it possible to estimate the number
of genes rendered accessible to trapping by the use of the
enhanced vectors. Using minimum expression level to
deﬁne trappability, numbers of trappable and untrappable
genes can be estimated and compared for the diﬀerent
vectors (Figure 7). As shown in Table 1, out of the 7435
genes of the Nord et al. (9) data set, the nonenhanced
FlipRosabgeo vector would be predicted to trap 5170
genes (70% of genes in the Nord et al. data set). This
value for percentage of genes accessible to gene trapping
is similar to a previous estimate for genome-wide trapp-
ability, which was based on 8000 full-length ENSEMBL
genes trapped in the existing resources (5). By comparison,
the use of the eFlipRosabgeo
  vector would be predicted
to increase the number of trappable genes in the Nord
et al. data set by about 15% (n=1108; Table 1). When
extrapolated to the entire genome, this suggests that
nearly 85% of annotated protein-coding genes may be
accessible through the use of enhanced gene trap vectors.
This overall increase in trappability appears to be distrib-
uted among functional categories of protein coding genes,
as the distribution of genes trapped with or without
enhancer is similar among the GeneOntology-deﬁned sub-
classes (Supplementary Table 3).
Finally, the OPE is likely to ﬁnd wider use beyond gene
trapping. For example, enhanced gene trapping cassettes
may increase the eﬀﬁciency of ‘targeted’ trapping, which
also requires gene expression (23). In addition, the OPE
may improve the performance of exogenous promoters
that drive the expression of selectable marker genes in
conventional gene targeting vectors.
In conclusion, the results described here are highly rele-
vant to the worldwide large-scale ESC mutagenesis pro-
grams started recently under the umbrella of the
International Knock Out Mouse Consortium (IKMC)
(24). The IKMC programs employ a combination of
gene trapping and gene targeting in the eﬀort to knock
Figure 7. Box-Plot of absolute gene expression levels of genes trapped
with the FlipRosabgeo vectors. Gene expression values for trapped
ENSEMBL genes were derived from the GEO series accession
GSE8128 (9). Box boundaries represent the ﬁrst and third quartiles
(Q.25,Q . 75). The median is indicated by the horizontal line dividing
the interquartile range. Upper and lower ticks indicate the 10th and
90th percentiles. The mean value is indicated by the dashed line
(also see Supplementary Table 1).
Table 1. Predicted numbers of trappable genes per gene trap vector
Gene trap vector Minimum expression level
a Predicted gene number Predicted saturation
(Nord et al. dataset) (%)
Trappable Untrappable
FlipRosabgeo 22.88 5170 2265 69.5
eFlipRosabgeo 9.95 5999 1436 80.7
FlipRosabgeo
a 14.71 5526 1909 74.3
eFlipRosabgeo
a 7.92 6278 1157 84.4
aAbsolute gene expression values were obtained from the GEO series accession GSE8128 (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE8128).
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mal balance between the two technologies is sought in
order to apply the most eﬃcient mutagenesis strategy
(24). Because trapping is cheaper and generally involves
less work, targeted mutagenesis is normally reserved for
genes that are least accessible via trapping. Accordingly,
genes well represented in gene trap libraries are generally
excluded from gene targeting. Based on the results pre-
sented here however, we predict that the enhanced gene
trapping approach will signiﬁcantly increase the pool of
genes accessible via trapping or targeting and thus reduce
the overall eﬀort and costs of the ongoing mouse muta-
genesis programs. Furthermore, these results provide
evidence that although gene-trapping vectors have been
widely used for almost two decades, the evolution of
these vectors is still ongoing and further vector innova-
tions have the potential to signiﬁcantly impact the acces-
sibility of genes for functional analyses.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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